- Supported exchanges /
- AU /
- OSL.AU
Oncosil Medical Ltd (OSL AU) stock market data APIs
OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.
Oncosil Medical Ltd Financial Data Overview
| 0.012 | |
| 0.012 | |
| - | |
| 0.013 | |
| 0.012 | |
| 0.004-0.014 | |
| 49 192 K | |
| 3 784 M | |
| 1 455 K | |
| 0.905 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Oncosil Medical Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 455 K
- EBITDA -12 112 061
- Earnings Per Share -0.01
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Oncosil Medical Ltd Earnings via APIs
- Latest Release 2024-08-30
- EPS/Forecast NaN
Get Oncosil Medical Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
